Khemla, Supphachoke, Atibordee Meesing, Wantin Sribenjalux, and Ploenchan Chetchotisakd. 2023. “Lipid Profiles of People With Human Immunodeficiency Virus With Dyslipidemia After Switching from Efavirenz to Dolutegravir”. Drug Target Insights 17 (1):45-53. https://doi.org/10.33393/dti.2023.2529.